During the past decade, RCMed Oddzial Warszawa conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "RCMed Oddzial Warszawa" are "Alopecia Areata" (5 trials), "Dermatitis, Atopic" (3 trials), "Dermatitis" (2 trials), "Eczema" (2 trials) and "Genetic Diseases, Inborn" (2 trials). Many other conditions were trialed in "RCMed Oddzial Warszawa" in a lesser frequency.

Most popular intervention types in "RCMed Oddzial Warszawa" are "Drug" (11 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "PF-04965842 100 mg" (2 trials), "PF-04965842 200 mg" (2 trials), "PF-06651600" (2 trials) and "ABP 501" (1 trials). Other intervention names were less common.

The vast majority of trials in "RCMed Oddzial Warszawa" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "RCMed Oddzial Warszawa". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in RCMed Oddzial Warszawa, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in RCMed Oddzial Warszawa, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".